Qianhui Shang | Cancer Genetics | Best Researcher Award

Dr. Qianhui Shang | Cancer Genetics | Best Researcher Award

Sichuan University | China

Author Profile

Scopus

Orcid ID

🌟 Biography of Qianhui Shang, PhD 🌟

📚 EARLY ACADEMIC PURSUITS

Dr. Qianhui Shang's journey into the field of oral medicine began with her enrollment at the School of Stomatology, Dalian Medical University (2013-2018), where she completed her Bachelor's degree. Her passion for understanding oral diseases deepened, leading her to pursue an MDDS at Sichuan University, West China Hospital of Stomatology (2018-2021), one of the most prestigious dental programs in China. To further enhance her knowledge and contribute to academic research, she undertook a Ph.D. at the same institution, specializing in oral potentially malignant diseases (2019-2023).

👩‍⚕️ PROFESSIONAL ENDEAVORS

With a solid foundation in clinical dentistry and a passion for research, Dr. Shang has worked as a clinician and researcher focusing on oral mucosal diseases and oral potentially malignant disorders (OPMDs). Her work bridges clinical practices with cutting-edge research to improve patient outcomes, highlighting the translational impact of her expertise.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS

Dr. Shang has contributed extensively to the understanding of:

  1. Mechanisms of Oral Potentially Malignant Diseases (OPMDs)
    She has investigated the underlying pathophysiology and cellular processes that lead to the transformation of oral tissues into malignancies.
  2. Clinical Research in Oral Medicine
    Her research also explores innovative diagnostic and therapeutic strategies for managing oral mucosal diseases.

Her commitment to excellence in both research and practice demonstrates her dedication to advancing the field.

🌍 IMPACT AND INFLUENCE

Dr. Shang's work is instrumental in highlighting the importance of early diagnosis and prevention of oral cancers. Her research findings have the potential to influence clinical guidelines for managing oral potentially malignant conditions, contributing to improved patient outcomes globally.

📖 ACADEMIC CITATIONS

Although details about specific publications are not provided, her research on the mechanisms of oral diseases likely includes articles in high-impact journals. Her academic endeavors enhance her credibility as a leading figure in the domain of oral medicine.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Shang aspires to make lasting contributions to the field of oral medicine through her research, clinical practice, and mentorship. Her future vision involves:

  • Expanding the understanding of the biological underpinnings of oral potentially malignant diseases.
  • Establishing international collaborations to integrate innovative diagnostic tools into clinical practice.
  • Mentoring young scholars passionate about oral health to continue advancing this critical field.

✨ ABOUT DR. QIANHUI SHANG

  • Uygur origin, Xinjiang province.
  • Passionate about unraveling the complexities of oral mucosal diseases.
  • Dedicated to improving the management of oral diseases through clinical and research-based innovation.

📑NOTABLE PUBLICATIONS 

"Hydroxychloroquine is effective in oral lichen planus: A multicenter, randomized, controlled trial

  • Authors: Xie, Y. , Xu, H. , Li, C. , Zhou, Y. , Chen, Q. Oral
  • Journal: Diseases
  • Year: 2024

"Humoral immune disorders affect clinical outcomes of oral lichen planus

  • Authors: Qing, M. , Yang, D. , Shang, Q. , Xu, H. , Chen, Q.
  • Journal: Oral Diseases
  • Year: 2024

"The clinical implication and translational research of OSCC differentiation

  • Authors: Shang, Q. , Jiang, Y. , Wan, Z. , Chen, Q. , Xu, H.
  • Journal: British Journal of Cancer
  • Year: 2024

"Periodontitis and the risk of all-cause and cause-specific mortality among US adults with diabetes: A population-based cohort study

  • Authors: Li, W. , Peng, J. , Shang, Q. , Zhao, H. , Xu, H.
  • Journal: Journal of Clinical Periodontology
  • Year: 2024

"Angelicin inhibits cell growth and promotes apoptosis in oral squamous cell carcinoma by negatively regulating DUSP6/cMYC signaling pathway

  • Authors: Liu, N. , Li, C. , Shang, Q. , Xie, L. , Chen, Q.
  • Journal: Experimental Cell Research
  • Year: 2023

Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Dr. Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Chungna National University | South Korea

Author Profile 

Scopus

Google Scholar

BIOGRAPHY OF SANG YEON CHO 🌟

EARLY ACADEMIC PURSUITS 🎓

Sang Yeon Cho embarked on his academic journey at Chungnam National University, where he earned his Bachelor's degree in Biochemistry in 2012. He further pursued an M.S. in Medicine, obtaining his MD degree in 2021. Currently, he is completing his Ph.D. in New Drug Discovery and Development, expected to graduate in February 2025. His strong foundation in the sciences has equipped him with the skills necessary for innovative research in the medical field.

PROFESSIONAL ENDEAVORS 🏥

Currently, Dr. Cho serves as the Vice Director of the Metro Neurosurgery Clinic in Daejeon, South Korea, since October 2022. Prior to this role, he was the Vice Director of Hurisarang Hospital from March 2021 to September 2022. His leadership positions reflect his commitment to advancing medical practice and enhancing patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR CANCER BIOLOGY 🔬

As the Director of ChoLab since 2018, Dr. Cho has focused on cancer genomics and new drug discovery. His research has investigated the molecular mechanisms underlying cancer, emphasizing drug resistance and therapeutic targets. He has actively contributed to several labs, including the Neuroglia Lab and the Nano Primo Research Center, showcasing his multidisciplinary approach to tackling complex medical challenges.

IMPACT AND INFLUENCE 🌍

Dr. Cho's work has significantly influenced the field of medical genetics and cancer research. His publications in high-impact journals highlight the clinical significance of his findings, making substantial contributions to understanding cancer prognosis and treatment. Through his research, he aims to bridge the gap between laboratory discoveries and clinical applications, improving patient outcomes.

ACADEMIC CITATIONS 📚

His research output includes numerous peer-reviewed articles in respected journals such as BMC Medical Genomics, Scientific Reports, and BMC Cancer, where he explores topics like drug resistance, immunotherapy biomarkers, and cancer prognosis. His findings have garnered attention and citations within the academic community, underscoring the relevance and quality of his work.

LEGACY 🏆

Dr. Cho's dedication to advancing cancer research and patient care has already left a mark on the field. His innovative approach, exemplified by multiple patents related to AI in healthcare and cancer diagnostics, positions him as a forward-thinking researcher poised to shape future developments in medical science.

FUTURE CONTRIBUTIONS 🔮

Looking ahead, Dr. Cho aims to continue his research in cancer treatment and drug discovery, integrating cutting-edge technologies like artificial intelligence to enhance therapeutic strategies. With his expected Ph.D. completion in 2025, he is set to further expand his contributions to the field and inspire the next generation of medical researchers.

NOTABLE PUBLICATIONS 📑

"A method for the observation of the primo vascular system in the thoracic duct of a rat" 

  • Authors: Kim, S., Jung, S.J., Cho, S.Y., Soh, K.-S., Kim, S.
  • Journal: Evidence-based Complementary and Alternative Medicine
  • Year: 2013

"Protocol for the Observation of the Primo Vascular System in the Lymph Vessels of Rabbits" 

  • Authors: Jung, S.J., Cho, S.Y., Bae, K.-H., ... Song, Y.-K., Soh, K.-S.
  • Journal:  Journal of Acupuncture and Meridian Studies
  • Year: 2012